Med-IQ

Course Listings: Rheumatology

Course Description: This publication highlights the unmet needs of patients with RA who do not respond or lose response to treatment and explores how applying current evidence-based guidelines for managing RA can improve outcomes through selecting appropriate therapy, monitoring response, and adjusting treatment. In addition, this activity discusses the advances that have occurred…More

Course Description: This educational activity discusses the diagnosis and treatment of hypophosphatemia associated with excess fibroblast growth factor-23 (FGF23), with a focus on X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) in adults, adolescents, and children. In addition, audio commentary by expert faculty Thomas O. Carpenter, MD, and Anthony A. Portale,…More

Course Description: Both the American College of Rheumatology and the European League Against Rheumatism are updating their guidelines for the management of rheumatoid arthritis (RA). In this case-based activity, faculty discuss how the new guidelines affect management approaches for various populations with RA, highlight important updates, and explain the rationale for changes in…More

Course Description: This supplement reviews key changes to the latest American College of Rheumatology (ACR) guidelines for rheumatoid arthritis (RA) and how they may be implemented to meet the unique needs of veterans. New priorities include minimizing/eliminating glucocorticoids; using methotrexate (MTX) as early first-line treatment and continuing it rather than rapidly…More

Course Description: This activity presents 3 different case scenarios of patients with uncontrolled RA and allows learners to determine optimal treatment strategies and interventions to promote adherence. Expert faculty provide insight on tailoring therapies based on a patient’s preferences and therapy goals, and learners will be able to see how their responses compare with those…More

Course Description: This 15-minute accredited CME publication reviews the benefits and limitations of antinuclear antibody (ANA) testing and its utility in systemic lupus erythematosus (SLE). Highlights include an examination of ANA expression in SLE, the role of ANA testing in clinical trials, challenges associated with currently available assays, and novel approaches for ANA…More